Memórias do Instituto Oswaldo Cruz · 2010 · 18 citations · 12 references
MedicineOncologyPharmacologyCancer PharmacologyChemotherapyOncology PharmacotherapyAntiparasitic ChemotherapyChagas DiseaseOncology PharmacologyProtozoal InfectionsProtozoan PathogenesisAcute Chagas DiseaseAntineoplastic Drug TherapyHalf-maximal Inhibitory ConcentrationIn Vivo Efficacy TestingParasite Life Cycle StagesTreatment Of TrypanosomiasisTrypanosoma Cruzi InfectionTrypanosoma Cruzi Life Cycle
The activity of the antineoplastic drug tamoxifen was evaluated against Trypanosoma cruzi. In vitro activity was determined against epimastigote, trypomastigote and amastigote forms of CL14, Y and Y benznidazole resistant T. cruzi strains. Regardless of the strain used, the drug was active against all life-cycle stages of the parasite with a half maximal effective concentration ranging from 0.7-17.9 µM. Two experimental models of acute Chagas disease were used to evaluate the in vivo efficacy of treatment with tamoxifen. No differences in parasitemia and mortality were observed between control mock-treated and tamoxifen-treated mice.
12
Comparative Genomics of Trypanosomatid Parasitic Protozoa
Najib M. El-Sayed, Peter J. Myler, Gaëlle Blandin et al. · Science · 2005 · 833 citations